Ignite Creation Date:
2025-12-18 @ 8:45 AM
Ignite Modification Date:
2025-12-18 @ 8:45 AM
Study NCT ID:
NCT03184571
Status:
None
Last Update Posted:
2025-09-25 00:00:00
First Post:
2017-05-30 00:00:00
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Bemcentinib (BGB324) in Combination With Pembrolizumab in Patients With Advanced Non-small Cell Lung Cancer (NSCLC)
Sponsor:
Organization: